Mayer, E., Gnant, M., DeMichele, A., Martin, M., Burstein, H., Prat, A., . . . Dueck, A. (2020). LBA12 PALLAS: A randomized phase III trial of adjuvant palbociclib with endocrine therapy versus endocrine therapy alone for HR+/HER2- early breast cancer. Annals of Oncology, 31, S1145. https://doi.org/10.1016/j.annonc.2020.08.2240
Chicago Style (17th ed.) CitationMayer, E.L, et al. "LBA12 PALLAS: A Randomized Phase III Trial of Adjuvant Palbociclib with Endocrine Therapy Versus Endocrine Therapy Alone for HR+/HER2- Early Breast Cancer." Annals of Oncology 31 (2020): S1145. https://doi.org/10.1016/j.annonc.2020.08.2240.
MLA (9th ed.) CitationMayer, E.L, et al. "LBA12 PALLAS: A Randomized Phase III Trial of Adjuvant Palbociclib with Endocrine Therapy Versus Endocrine Therapy Alone for HR+/HER2- Early Breast Cancer." Annals of Oncology, vol. 31, 2020, p. S1145, https://doi.org/10.1016/j.annonc.2020.08.2240.